A novel sublingual apomorphine treatment
โ
William Ondo; Christine Hunter; Michael Almaguer; Joseph Jankovic
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 60 KB
๐ 2 views
We tested a novel preparation of a sublingual apomorphine hydrochloride tablet (APO) in 10 patients with advanced Parkinson's disease complicated by motor fluctuations. After a dose titration, patients took either 40 mg APO three times per day alternating with levodopa doses (eight patients) or six